Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study

Authors

Institutions

Publication Details

Journal
Infection and Drug Resistance
Published
2025-07-01
DOI
https://doi.org/10.2147/idr.s516991
Citations
5
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
6.98

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study

Naihui Chu, Wenjuan Nie, Yu Xue, Liping Ma et al.
5 citations
Infection and Drug Resistance
Tuberculosis Research and Epidemiology
6.98
article

Safety and Tolerability of Contezolid Versus Linezolid for Short-Term Treatment of Rifampicin-Resistant Pulmonary Tuberculosis: A Randomized Controlled Study

Naihui Chu, Wenjuan Nie, Yu Xue, Liping Ma, Jun Wang, Yadong Du
article en
5 citations

Abstract

No abstract available for this paper.
Infection and Drug ResistanceVol. Volume 18
Beijing Chest Hospital (CN)
National Natural Science Foundation of China, Capital Medical University
Good health and well-being
Openalex Percentile: Top 3%
Tuberculosis Research and Epidemiology
6.98
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.